Skip to main content
TipRanks
Go Ultimate75% OFF

Achieve Life Sciences (SP4P) Stock Statistics & Valuation Metrics

3 Followers

Total Valuation

Achieve Life Sciences has a market cap or net worth of EUR 550.53M. The enterprise value is EUR 665.84M.

Market Cap
EUR 550.53M
Enterprise Value
EUR 665.84M

Share Statistics

Achieve Life Sciences has 102,902,490 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
102,902,490
Owned by Insiders
0.22%
Owned by Institutions
80.18%

Financial Efficiency

Achieve Life Sciences’s return on equity (ROE) is -2.54 and return on invested capital (ROIC) is -150.47%.

Return on Equity (ROE)
-2.54
Return on Assets (ROA)
-1.31
Return on Invested Capital (ROIC)
-150.47%
Return on Capital Employed (ROCE)
-1.68
Revenue Per Employee
0
Profits Per Employee
-1.95M
Employee Count
28
Asset Turnover
0.00
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of Achieve Life Sciences is -4.03. Achieve Life Sciences’s PEG ratio is 0.23.

PE Ratio
-4.03
PS Ratio
0.00
PB Ratio
3.24
Price to FCF
-12.98
Price to Operating Cash Flow
-13.32
PEG Ratio
0.23

Income Statement

In the last 12 months, Achieve Life Sciences had revenue of 0 and earned -54.65M in profits. Earnings per share was -1.25.

Revenue
0
Gross Profit
-228.00K
Operating Income
-54.88M
Pretax Income
-54.65M
Net Income
-54.65M
EBITDA
-53.60M
Earnings Per Share (EPS)
-1.25

Cash Flow

In the last 12 months, operating cash flow was -44.04M and capital expenditures -52,000, giving a free cash flow of -44.09M billion.

Operating Cash Flow
-44.04M
Free Cash Flow
-44.09M
Free Cash Flow per Share
-0.42

Dividends & Yields

Achieve Life Sciences pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-7.71%
Earnings Yield
-19.07%

Stock Price Statistics

Beta
1.43
52-Week Price Change
46.37%
50-Day Moving Average
6.20
200-Day Moving Average
4.94
Relative Strength Index (RSI)
37.95
Average Volume (3m)
193

Important Dates

Achieve Life Sciences upcoming earnings date is Mar 11, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 10, 2026
Next Earnings Date
Mar 11, 2027
Ex-Dividend Date
―

Financial Position

Achieve Life Sciences as a current ratio of 4.39, with Debt / Equity ratio of 69.50%

Current Ratio
4.39
Quick Ratio
4.39
Debt to Market Cap
0.07
Net Debt to EBITDA
0.11
Interest Coverage Ratio
-67.01

Taxes

In the past 12 months, Achieve Life Sciences has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

Achieve Life Sciences EV to EBITDA ratio is -4.69, with an EV/FCF ratio of -11.92.

EV to Sales
0.00
EV to EBITDA
-4.69
EV to Free Cash Flow
-11.92
EV to Operating Cash Flow
-11.93

Balance Sheet

Achieve Life Sciences has EUR 201.52M in cash and marketable securities with EUR 13.76M in debt, giving a net cash position of EUR 187.76M billion.

Cash & Marketable Securities
EUR 201.52M
Total Debt
EUR 13.76M
Net Cash
EUR 187.76M
Net Cash Per Share
EUR 1.82
Tangible Book Value Per Share
EUR 1.70

Margins

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

Gross Margin
0.00%
Operating Margin
0.00%
Pretax Margin
0.00%
Net Profit Margin
0.00%
EBITDA Margin
0.00%
EBIT Margin
0.00%

Analyst Forecast

The average price target for Achieve Life Sciences is EUR 12.05, which is 11.43% higher than the current price. The consensus rating is Strong Buy

Price Target
EUR 12.05
Price Target Upside
125.27% Upside
Analyst Consensus
Strong Buy
Analyst Count
7
Revenue Growth Forecast
―
EPS Growth Forecast
5.28%

Scores

Smart Score
6
AI Score
―